Wiley Bros. Aintree Capital, LLC Charles River Laboratories International, Inc. Transaction History
Wiley Bros. Aintree Capital, LLC
- $9.13 Billion
- Q1 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 8,745 shares of CRL stock, worth $1.29 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,745
Previous 7,617
14.81%
Holding current value
$1.29 Million
Previous $1.41 Million
6.4%
% of portfolio
0.01%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding CRL
# of Institutions
648Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$900 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$750 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$632 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$353 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$288 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.5B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...